Prevalence and prognostic value of activated protein C resistance and anti–protein C antibodies in patients with aPLs: an APS ACTION Registry study

Ibrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, Vittorio Pengo, Diana Parades-Ruiz, D Ware Branch, Maria Gerosa, Cecilia Nalli, Esther Rodriguez Almaraz, Michelle Petri, Ricard Cervera, Olga Amengual, Danieli de Andrade, Rohan Willis, Maria Laura Bertolaccini, Doruk Erkan, Hannah Cohen, Maria Efthymiou

Open source

DOI: 10.1093/rheumatology/keag304
Published: 2026-06-13
Container: Rheumatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag304,
  title = {Prevalence and prognostic value of activated protein C resistance and anti–protein C antibodies in patients with aPLs: an APS ACTION Registry study},
  author = {Ibrahim Tohidi-Esfahani and Veronica Venturelli and Maria Tektonidou and Vittorio Pengo and Diana Parades-Ruiz and D Ware Branch and Maria Gerosa and Cecilia Nalli and Esther Rodriguez Almaraz and Michelle Petri and Ricard Cervera and Olga Amengual and Danieli de Andrade and Rohan Willis and Maria Laura Bertolaccini and Doruk Erkan and Hannah Cohen and Maria Efthymiou},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keag304},
  url = {https://doi.org/10.1093/rheumatology/keag304}
}

RIS

TY  - JOUR
TI  - Prevalence and prognostic value of activated protein C resistance and anti–protein C antibodies in patients with aPLs: an APS ACTION Registry study
AU  - Ibrahim Tohidi-Esfahani
AU  - Veronica Venturelli
AU  - Maria Tektonidou
AU  - Vittorio Pengo
AU  - Diana Parades-Ruiz
AU  - D Ware Branch
AU  - Maria Gerosa
AU  - Cecilia Nalli
AU  - Esther Rodriguez Almaraz
AU  - Michelle Petri
AU  - Ricard Cervera
AU  - Olga Amengual
AU  - Danieli de Andrade
AU  - Rohan Willis
AU  - Maria Laura Bertolaccini
AU  - Doruk Erkan
AU  - Hannah Cohen
AU  - Maria Efthymiou
PY  - 2026
JO  - Rheumatology
DO  - 10.1093/rheumatology/keag304
UR  - https://doi.org/10.1093/rheumatology/keag304
ER  -

APA

Tohidi-Esfahani, I., Venturelli, V., Tektonidou, M., Pengo, V., Parades-Ruiz, D., Branch, D. W., Gerosa, M., Nalli, C., Almaraz, E. R., Petri, M., Cervera, R., Amengual, O., Andrade, D. D., Willis, R., Bertolaccini, M. L., Erkan, D., Cohen, H., & Efthymiou, M. (2026). Prevalence and prognostic value of activated protein C resistance and anti–protein C antibodies in patients with aPLs: an APS ACTION Registry study. Rheumatology. https://doi.org/10.1093/rheumatology/keag304

Source records

crossref · retrieved 2026-09-27T12:09:38.554Z